These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 3046382)

  • 1. S-adenosylmethionine treatment of depression: a controlled clinical trial.
    Bell KM; Plon L; Bunney WE; Potkin SG
    Am J Psychiatry; 1988 Sep; 145(9):1110-4. PubMed ID: 3046382
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral S-adenosylmethionine in depression: a randomized, double-blind, placebo-controlled trial.
    Kagan BL; Sultzer DL; Rosenlicht N; Gerner RH
    Am J Psychiatry; 1990 May; 147(5):591-5. PubMed ID: 2183633
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Controlled double-blind study (SAMe-imipramine) in depressive syndromes].
    Mantero M; Pastorino P; Carolei A; Agnoli A
    Minerva Med; 1975 Nov; 66(78):4098-101. PubMed ID: 1103017
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Open trial of S-adenosylmethionine for treatment of depression.
    Lipinski JF; Cohen BM; Frankenburg F; Tohen M; Waternaux C; Altesman R; Jones B; Harris P
    Am J Psychiatry; 1984 Mar; 141(3):448-50. PubMed ID: 6367496
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and tolerability of oral and intramuscular S-adenosyl-L-methionine 1,4-butanedisulfonate (SAMe) in the treatment of major depression: comparison with imipramine in 2 multicenter studies.
    Delle Chiaie R; Pancheri P; Scapicchio P
    Am J Clin Nutr; 2002 Nov; 76(5):1172S-6S. PubMed ID: 12418499
    [TBL] [Abstract][Full Text] [Related]  

  • 6. S-adenosylmethionine in depression. A literature review and preliminary report.
    Janicak PG; Lipinski J; Davis JM; Comaty JE; Waternaux C; Cohen B; Altman E; Sharma RP
    Ala J Med Sci; 1988 Jul; 25(3):306-13. PubMed ID: 3052139
    [No Abstract]   [Full Text] [Related]  

  • 7. Rapid antidepressant response with SAMe. A double-blind study.
    Potkin SG; Bell K; Plon L; Bunney WE
    Ala J Med Sci; 1988 Jul; 25(3):313-6. PubMed ID: 3052140
    [No Abstract]   [Full Text] [Related]  

  • 8. Maprotiline versus imipramine and placebo in neurotic depression.
    van der Velde CD
    J Clin Psychiatry; 1981 Apr; 42(4):138-41. PubMed ID: 7009592
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nomifensine vs. imipramine in depressed inpatients.
    Fann WE; Lyle FA; Higginbotham W
    J Clin Psychiatry; 1984 Apr; 45(4 Pt 2):60-2. PubMed ID: 6370978
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Viloxazine HCl in the treatment of endogenous depression: a standard (imipramine) controlled clinical study.
    McEvoy JP; Libiger J; Wilson WH; Ban TA; Berney S; Guy W
    J Clin Psychiatry; 1982 Mar; 43(3):111-2. PubMed ID: 7037758
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of S-adenosyl-L-methionine in speeding the onset of action of imipramine.
    Berlanga C; Ortega-Soto HA; Ontiveros M; Senties H
    Psychiatry Res; 1992 Dec; 44(3):257-62. PubMed ID: 1289923
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rolipram in major depressive disorder: results of a double-blind comparative study with imipramine.
    Hebenstreit GF; Fellerer K; Fichte K; Fischer G; Geyer N; Meya U; Sastre-y-Hernández M; Schöny W; Schratzer M; Soukop W
    Pharmacopsychiatry; 1989 Jul; 22(4):156-60. PubMed ID: 2668980
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early clinical double-blind study with S-adenosyl-L-methionine: a new potential antidepressant.
    Küfferle B; Grünberger J
    Adv Biochem Psychopharmacol; 1982; 32():175-80. PubMed ID: 7046363
    [No Abstract]   [Full Text] [Related]  

  • 14. Minaprine and imipramine in the treatment of major depressive disorders. A comparative double-blind study.
    Bohacek N; Ravic M; Bizière K
    Drugs Exp Clin Res; 1987; 13(7):435-42. PubMed ID: 3308390
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multicenter double-blind comparison of nomifensine and imipramine for efficacy and safety in depressed outpatients.
    Bremner JD; Abrahams LM; Crupie JE; McCawley A; Proctor RC; Sathananthan GL
    J Clin Psychiatry; 1984 Apr; 45(4 Pt 2):56-9. PubMed ID: 6370976
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fluoxetine in depressed patients: a comparison with imipramine.
    Bremner JD
    J Clin Psychiatry; 1984 Oct; 45(10):414-9. PubMed ID: 6384203
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ritanserin, imipramine, and placebo in the treatment of dysthymic disorder.
    Bakish D; Lapierre YD; Weinstein R; Klein J; Wiens A; Jones B; Horn E; Browne M; Bourget D; Blanchard A
    J Clin Psychopharmacol; 1993 Dec; 13(6):409-14. PubMed ID: 8120154
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SAMe versus placebo: a double blind comparison in major depressive disorders.
    Muscettola G; Galzenati M; Balbi A
    Adv Biochem Psychopharmacol; 1982; 32():151-6. PubMed ID: 7046362
    [No Abstract]   [Full Text] [Related]  

  • 19. An outpatient evaluation of phenelzine and imipramine.
    Davidson J; Raft D; Pelton S
    J Clin Psychiatry; 1987 Apr; 48(4):143-6. PubMed ID: 3549705
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A double-blind clinical trial of alprazolam, imipramine, or placebo in the depressed elderly.
    Weissman MM; Prusoff B; Sholomskas AJ; Greenwald S
    J Clin Psychopharmacol; 1992 Jun; 12(3):175-82. PubMed ID: 1629383
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.